Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices.
about
Stem cell therapy and tissue engineering for correction of congenital heart diseaseCardiovascular Regenerative Technologies: Update and Future OutlookDecellularized tissue-engineered heart valve leaflets with recellularization potentialDevelopment of an ovine model of pediatric complete heart blockNon-invasive multiphoton imaging of extracellular matrix structures.Comparison of Mesenchymal Stem Cell Source Differentiation Toward Human Pediatric Aortic Valve Interstitial Cells within 3D Engineered Matrices.Introduction. Bioengineering the heart.Immunoproteomic identification of bovine pericardium xenoantigensBiological matrices and bionanotechnology.Medical application of microbial biopolyesters polyhydroxyalkanoates.Tissue engineering on matrix: future of autologous tissue replacement.Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.Heart valve regeneration: the need for systems approaches.Variation in tissue outcome of ovine and human engineered heart valve constructs: relevance for tissue engineering.Supercritical carbon dioxide-based sterilization of decellularized heart valves.Developing a Clinically Relevant Tissue Engineered Heart Valve-A Review of Current Approaches.Improving the biological function of decellularized heart valves through integration of protein tethering and three-dimensional cell seeding in a bioreactor.Sequential hydrophile and lipophile solubilization as an efficient method for decellularization of porcine aortic valve leaflets: Structure, mechanical property and biocompatibility study.
P2860
Q26801514-1FB8CD3C-91B3-4DB5-BE8A-14BE3928092AQ28067086-5497BFC3-6C31-4C1C-BA71-AAB3E2535535Q34454174-17B4DD0D-D552-4278-97E7-BE62BB5F9F45Q34777049-6E548CC5-2311-4795-964F-7E521822CB9EQ35151678-61B4C945-0F00-4D7A-A922-9EB88B0CBA27Q35910816-FA398249-DCE2-4905-8DD1-C46B73A24819Q36093418-D310CB8F-97AC-4A9D-B2CD-23DB01C574C3Q36841930-294B93CD-EA2F-4BE1-B6A8-2A7871C9B208Q36854397-D813B0C2-107D-4EDA-B00C-33DA58C93B5AQ37365335-8B0CF1E3-E1EB-4CFD-8F76-0200FE827397Q37833522-2AD8729F-CE19-4FCC-84C6-0DCFA14B49D6Q38076751-0E5F2023-DDD5-44A6-98EF-924C3FC091E7Q38728008-30D84D07-E870-44C4-883C-430FD5CF92A4Q39675828-13D3BB97-136A-4147-BD7F-3E9F314C07FBQ42315226-E568AA27-9B0E-4376-9A1F-087EE359EF58Q47317443-69347999-2359-4A84-B234-25EEA63742F3Q47324546-C29A1734-25EB-469A-9AD0-90EC94B87801Q51081150-2A3C8A80-1CFF-4585-A1B0-DB0C30AD0BF9
P2860
Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tissue engineering of heart va ...... or polymeric starter matrices.
@en
type
label
Tissue engineering of heart va ...... or polymeric starter matrices.
@en
prefLabel
Tissue engineering of heart va ...... or polymeric starter matrices.
@en
P2093
P2860
P356
P1476
Tissue engineering of heart va ...... or polymeric starter matrices.
@en
P2093
Dörthe Schmidt
Simon P Hoerstrup
Ulrich A Stock
P2860
P304
P356
10.1098/RSTB.2007.2131
P407
P577
2007-08-01T00:00:00Z